CVN424 75 mg clinical trials

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

This study is testing a new medicine, CVN424, for people with Parkinson's disease who experience 'OFF' times (when their medication isn't working as well). It aims to see if CVN424 can help reduce these 'OFF' periods. Participants will take the medicine or a dummy pill for 12 weeks.